22nd International AIDS Conference

23-27 July 2018
Amsterdam, the Netherlands

Side event on ending paediatric HIV, presentation on the LIVING study on paediatric HIV, two panel discussions, and poster discussion on TB/HIV co-treatment, and poster on caregiver adherence to oral lopinavir/ritonavir pellets to treat children.

Also: pre-conference workshop session on viral suppression in children taking oral LPV/r

PAGE 2018 Meeting

29 May-1 June 2018
Montreux, Switzerland
DNDi – poster presentation on TB/HIV paediatric co-treatment

MSF Scientific Days 2018

24-25 May 2018
London, UK
Olawale Salami, Paediatric HIV Clinical Project Manager DNDi Africa – poster about the LIVING study on treatment for paediatric HIV

Geneva Health Forum

7th Edition: Precision Global Health in the Digital Age

10-12 April 2018
Geneva, Switzerland
Bernard Pécoul, Executive Director – plenary talk on emerging infectious diseases crisis
Digas Ngolo, Investigator Coordinator, DNDi Africa – parallel session on ehealth

CROI 2018

4-7 March 2018
Boston, USA
DNDi – posters on Paediatric HIV treatments and on drugs interactions in HCV+/-HIV infected adults

The 8th KASH Conference

14-16 February 2018
Nairobi, Kenya
Olawale Salami, Paediatric HIV Clinical Project Manager DNDi Africa – presentation of the results of a prospective study on Paediatric HIV.
Monique Wasunna, Director DNDi Africa, and Olawale Salami, Paediatric HIV Clinical Project Manager DNDi Africa – symposium on fighting for neglected patients.

DNDi reçoit le Prix 2017 de l’Innovation à Genève pour récompenser son action en faveur des populations les plus négligées

A l’occasion de l’Evénement économique 2017 du 9 novembre dernier, la Chambre de commerce, d’industrie et des services de Genève (CCIG), le Département de la sécurité et de l’économie (DSE) et l’Office de Promotion des Industries et des Technologies (OPI) ont décerné le Prix 2017 de l’innovation à l’initiative Médicaments contre les Maladies Négligées (DNDi).

ICASA 2017

December 4-9, 2017
Abidjan, Côte d’Ivoire
DNDi participated at the event.

More than EUR 56 million raised to fund initiative to fight antibiotic resistance

[Berlin – 4 September 2017]
Germany hosts pledging event for GARDP, a new initiative to develop new antibiotic treatments
Germany together with a number of countries and foundations today pledged EUR 56.5 million to help develop new treatments to fight against antibiotic resistance, during a fundraising event for the Global Antibiotic Research and Development Partnership (GARDP), hosted in Berlin by the German Federal Ministry of Health and the German Federal Ministry of Education and Research.
[Deutsch]

Gröhe: „Wichtiger Schritt im Kampf gegen Antibiotika-Resistenzen“

[Berlin – 4 September 2017]
Mehr als 56 Millionen Euro für die Erforschung und Entwicklung neuer Antibiotika zugesagt
Mit 56,5 Millionen Euro wollen die Bundesrepublik Deutschland und weitere internationale Geldgeber die Erforschung und Entwicklung neuer Antibiotika vorantreiben. Die Mittel wurden der Globalen Partnerschaft für Antibiotika-Forschung und Entwicklung – GARDP (Global Antibiotic Research and Development Partnership) – im Rahmen einer Veranstaltung auf Einladung von Bundesgesundheitsminister Hermann Gröhe und Georg Schütte, Staatssekretär im Bundesministerium für Bildung und Forschung, in Berlin zugesagt.
[English]